CELG-RI
Bristol-Myers Squibb Company Ce
5-year outlook
For information only — not financial advice.
Five-year outlook
Fair values and forward P/E anchor the model; bear, base, and bull show implied annual returns if price moved to each fair-value anchor over five years.
Fair value & forward multiple
DCF Value
$138.61
Main approach — DCF
107,183.3% margin
MarketSnap Value
$109.17
Pre-calculated + market intelligence
84,396.9% margin
Fair Value Confidence: Low
Forward P/E (5Y)
0.03×
Price ÷ year-5 avg EPS estimate
DCF Value: Headline fair value is about 1,072.8× the reference price — far outside the usual 12× display band. Treat as a model stress test, not a price target.
MarketSnap Value: Headline fair value is about 845.0× the reference price — far outside the usual 12× display band. Treat as a model stress test, not a price target.
Illustrative $10,000 after 5 years
| Scenario | Value in 5 years | CAGR |
|---|---|---|
| Bear | $6,105,548 | +260.70% |
| Base | $8,449,690 | +284.92% |
| Bull | $14,741,462 | +330.24% |
Figures are rough annualized paths to our bear, base, and bull value anchors — not a prediction of yearly returns.
Bear, base & bull paths (CAGR)
Financial quality
Overall 70/100
- Profitability Moderate
- Balance sheet Healthy
- Cash flow stability Healthy
- Shareholder dilution Low
- Business predictability Medium
Cash flow stability · Healthy
Operating cash flow and capital spending both rose; free cash flow remained positive.
Show OCF, CapEx and FCF
| Period end | OCF | CapEx | FCF | CapEx / OCF |
|---|---|---|---|---|
| 2023-12-31 | $13.9B | $1.2B | $12.7B | 8.7% |
| 2024-12-31 | $15.2B | $1.3B | $13.9B | 8.2% |
| 2025-12-31 | $14.2B | $1.3B | $12.9B | 9.3% |
Measures historical free-cash-flow positivity and stability, not future cash generation.
Source: Company cash-flow statements (reported) Reporting periods: 2023-12-31, 2024-12-31, 2025-12-31
Investment style fit
Best suited for
Data confidence
Log in for full outcome drivers, what must go right, what can go wrong, AI Reality Check, and personalized valuation tools.
Log in to continue
Log in to see the full 5-year outlook — drivers, risks, AI tools, and your saved valuations.
Login — it's free